The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Cellular senescence impairs the reversibility of pulmonary arterial hypertension
Open accessAbstract
Pulmonary arterial hypertension (PAH) in congenital cardiac shunts can be reversed by hemodynamic unloading (HU) through shunt closure. However, this reversibility potential is lost beyond a certain point in time. The reason why PAH becomes irreversible is unknown. In this study, we used MCT+shunt-induced PAH in rats to identify a dichotomous reversibility response to HU, similar to the human situation. We compared vascular profiles of reversible and irreversible PAH using RNA sequencing. Cumulatively, we report that loss of reversibility is associated with a switch from a proliferative to a senescent vascular phenotype and confirmed markers of senescence in human PAH-CHD tissue. In vitro, we showed that human pulmonary endothelial cells of patients with PAH are more vulnerable to senescence than controls in response to shear stress and confirmed that the senolytic ABT263 induces apoptosis in senescent, but not in normal, endothelial cells. To support the concept that vascular cell senescence is causal to the irreversible nature of end-stage PAH, we targeted senescence using ABT263 and induced reversal of the hemodynamic and structural changes associated with severe PAH refractory to HU. The factors that drive the transition from a reversible to irreversible pulmonary vascular phenotype could also explain the irreversible nature of other PAH etiologies and provide new leads for pharmacological reversal of end-stage PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Van der Feen and colleagues 36 showed that intraperitoneal administration of ABT263 (10 mg/kg daily for 7 days) reversed vascular remodelling and improved pulmonary haemodynamics in the end stage of shuntinduced pulmonary arterial hypertension in a rat model.36”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454
Mechanisms and functions of cellular senescence
Herranz, N., & Gil, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95148 · Cited by 1,232
Matrix metalloproteinases and angiogenesis
Rundhaug, J. E. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00355.x · Cited by 978
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 881
Self-citationStenmark, K. R., Meyrick, B. O., Galiè, N., Mooi, W. J., & McMurtry, I. F. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2009 · Cited by 777
Roos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 672
Self-citation
Cited by
Sorted by citations
Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000096 · Cited by 1,205
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Mechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 521
Senescence mechanisms and targets in the heart
Chen, M. S., Lee, R. T., & Garbern, J. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab161 · Cited by 353
Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Evans, C. E., Cober, N. D., Dai, Z., Stewart, D. J., & Zhao, Y. (2021) · European Respiratory Journal · doi:10.1183/13993003.03957-2020 · Cited by 336
Lagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Endothelial dysfunction: molecular mechanisms and clinical implications
Wang, X., & He, B. (2024) · MedComm · doi:10.1002/mco2.651 · Cited by 307
Han, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201
Cellular Senescence in Cardiovascular Diseases: A Systematic Review
Hu, C., Zhang, X., Teng, T., Ma, Z., & Tang, Q. (2022) · Aging and Disease · doi:10.14336/ad.2021.0927 · Cited by 184
Pathology and pathobiology of pulmonary hypertension: current insights and future directions
Guignabert, C., Aman, J., Bonnet, S., Dorfmüller, P., Olschewski, A., Pullamsetti, S. S., Rabinovitch, M., SCHERMULY, R. T., Humbert, M. J. C., & Stenmark, K. R. (2024) · European Respiratory Journal · doi:10.1183/13993003.01095-2024 · Cited by 178
Self-citationPathophysiology and new advances in pulmonary hypertension
Bousseau, S., Fais, R. S., Gu, S., Frump, A. L., & Lahm, T. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000137 · Cited by 171
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression
Born, E., Lipskaia, L., Breau, M., Houssaini, A., Beaulieu, D., Marcos, E., Pierre, R., Do Cruzeiro, M., Lefevre, M., Derumeaux, G., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.058794 · Cited by 148
Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
Kurakula, K., Smolders, V. F. E. D., Tura-Ceide, O., Jukema, J. W., Quax, P. H. A., & Goumans, M. (2021) · Biomedicines · doi:10.3390/biomedicines9010057 · Cited by 148
Self-citationThe costs and benefits of senotherapeutics for human health
Raffaele, M., & Vinciguerra, M. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00300-7 · Cited by 140
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Carpenter, V. J., Saleh, T., & Gewirtz, D. A. (2021) · Cancers · doi:10.3390/cancers13040723 · Cited by 124
New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Bu, L.-L., Yuan, H., Xie, L., Guo, M.-H., Liao, D., & Zheng, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015160 · Cited by 133
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison, G. M., Tchkonia, T., & Kirkland, J. L. (2023) · Cells · doi:10.3390/cells12091296 · Cited by 119
Embracing the challenges of neonatal and paediatric pulmonary hypertension
Ivy, D. D., Rosenzweig, E. B., Abman, S. H., Beghetti, M., Bonnet, D., Douwes, J. M., Manes, A., & Berger, R. M. F. (2024) · European Respiratory Journal · doi:10.1183/13993003.01345-2024 · Cited by 104
Self-citationPhenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension
Lechartier, B., Berrebeh, N., Huertas, A., Humbert, M. J. C., Guignabert, C., & Tu, L. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.08.040 · Cited by 96
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations
Mansfield, L., Ramponi, V., Gupta, K., Stevenson, T., Mathew, A. B., Barinda, A. J., Herbstein, F., & Morsli, S. (2024) · npj Aging · doi:10.1038/s41514-024-00181-1 · Cited by 88
Frataxin deficiency promotes endothelial senescence in pulmonary hypertension
Culley, M. K., Zhao, J., Tai, Y., Tang, Y., Perk, D., Negi, V., Yu, Q., Woodcock, C.-. C., Handen, A. L., Speyer, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136459 · Cited by 81
Self-citationEndothelial Senescence: A New Age in Pulmonary Hypertension
Culley, M. K., & Chan, S. Y. (2022) · Circulation Research · doi:10.1161/circresaha.121.319815 · Cited by 71
Bloom, S. I., Liu, Y., Tucker, J. R., Islam, M. T., Machin, D. R., Abdeahad, H., Thomas, T. G., Bramwell, R. C., Lesniewski, L. A., & Donato, A. J. (2023) · Aging Cell · doi:10.1111/acel.13875 · Cited by 73
Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects
Picos, A., Seoane, N., Campos‐Toimil, M., & Viña, D. (2025) · Biogerontology · doi:10.1007/s10522-025-10256-5 · Cited by 84
Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension
Cober, N. D., VandenBroek, M. M., Ormiston, M. L., & Stewart, D. J. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18261 · Cited by 61
Therapeutic opportunities for senolysis in cardiovascular disease
Sweeney, M. D., Cook, S. A., & Gil, J. (2022) · FEBS Journal · doi:10.1111/febs.16351 · Cited by 54
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression
Kohli, J. S., Chen, G., Fitsiou, E., Doepner, M., Brandenburg, S. M., Faller, W. J., Ridky, T. W., & Demaria, M. (2022) · Nature Communications · doi:10.1038/s41467-022-35657-9 · Cited by 45
Self-citationZeng, C. C., Liu, J., Zheng, X., Hu, X., & He, Y. (2023) · Respiratory Research · doi:10.1186/s12931-023-02559-3 · Cited by 43
Ramadhiani, R., Ikeda, K., Miyagawa, K., Ryanto, G. R. T., Tamada, N., Suzuki, Y., Kirita, Y., Matoba, S., Hirata, K., & Emoto, N. (2023) · iScience · doi:10.1016/j.isci.2023.106662 · Cited by 41
RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension
Piper, B., Bogamuwa, S., Hossain, T., Farkas, D., Rosas, L., Green, A. C., Newcomb, G., Sun, N., Ovando-Ricardez, J. A., Horowitz, J. C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169441 · Cited by 39
Anti-ageing interventions for the treatment of cardiovascular disease
Abdellatif, M., Schmid, S., Fuerlinger, A., & Kroemer, G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae177 · Cited by 44
Tracy, E. P., Hughes, W. E., Beare, J. E., Rowe, G., Beyer, A., & LeBlanc, A. J. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0031 · Cited by 39
Potential Clinical Implications of Senotherapies for Cardiovascular Disease
Suda, M., Katsuumi, G., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0657 · Cited by 37
Senescence Alterations in Pulmonary Hypertension
Roger, I., Milara, J., Belhadj, N., & Cortijo, J. (2021) · Cells · doi:10.3390/cells10123456 · Cited by 41
Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension
Shen, Y.-H., Ding, D., Lian, T., Qiu, B., Yan, Y., Wang, P., Zhang, W., & Jing, Z. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.10.004 · Cited by 34
Shinohara, T., Moonen, J.-R. A. J., Chun, Y. H., Lee-Yow, Y. C., Okamura, K., Szafron, J. M., Kaplan, J., Cao, A., Wang, L., Guntur, D., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321092 · Cited by 33
Self-citationZhang, J., Xu, C., Tang, X., Sun, S., Liu, S.-Q., Yang, L., Chen, Y., Yang, Q., Wei, T. W., Wu, X., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae011 · Cited by 29
Duan, R., Jiang, L., Wang, T., Li, Z., Yu, X., Gao, Y., Jia, R., Fan, X., & Su, W. (2024) · Nature Communications · doi:10.1038/s41467-024-55164-3 · Cited by 33
Antiaging Vaccines Targeting Senescent Cells
Mendelsohn, A. R., & Larrick, J. W. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0008 · Cited by 29
Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension
Isobe, S., Nair, R. V., Kang, H. Y., Wang, L., Moonen, J.-R. A. J., Shinohara, T., Cao, A., Taylor, S., Otsuki, S., Marciano, D. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43039-y · Cited by 32
Self-citationBmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension
Li, K., Li, Y., Yu, Y., Ding, J., Huang, H., Chu, C., Hu, L., Yu, Y., Cao, Y. Z., Xu, P., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01439-0 · Cited by 25
Anti-remodeling therapies in pulmonary arterial hypertension
Boucherat, O., Bonnet, S., Provencher, S., & Potus, F. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.05.004 · Cited by 25
Ozdemir, S. A., Faizan, M. I., Kaur, G., Shaikh, S. B., Islam, K. U., & Rahman, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199687 · Cited by 28
Mavrogiannis, E., Hagdorn, Q. A. J., Bazioti, V., Douwes, J. M., van der Feen, D. E., Oberdorf‐Maass, S. U., Westerterp, M., & Berger, R. M. F. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12101 · Cited by 25
Self-citationEndothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression
Kyi, P., Hendee, K., Hunyenyiwa, T., Matus, K., Mammoto, T., & Mammoto, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.908639 · Cited by 24
Dong, M. L., Lan, I. S., Yang, W., Rabinovitch, M., Feinstein, J. A., & Marsden, A. L. (2021) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-021-01519-4 · Cited by 21
Self-citationTherapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 23
Qamsari, E. S., & Stewart, D. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403669 · Cited by 22
Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention
Wiedemann, J., Coppes, R. P., & van Luijk, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.931023 · Cited by 20
Aging at the Crossroads of Organ Interactions: Implications for the Heart
Sen, I., Trzaskalski, N. A., Hsiao, Y., Liu, P. P., Shimizu, I., & Dérumeaux, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325637 · Cited by 20
Accelerated Cardiac Aging in Patients With Congenital Heart Disease
Iacobazzi, D., Alvino, V. V., Caputo, M., & Madeddu, P. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.892861 · Cited by 19
Potential role of cellular senescence in pulmonary arterial hypertension
Liu, L., Wei, Y., Giunta, S., He, Q., & Xia, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13696 · Cited by 18
A single-cell atlas of lung homeostasis reveals dynamic changes during development and aging
Jia, H., Chang, Y., Chen, Y., Chen, X., Zhang, H., Hua, X., Xu, M., Sheng, Y., Zhang, N., Cui, H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06111-x · Cited by 21
Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension
Ryanto, G. R. T., Musthafa, A., Hara, T., & Emoto, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043332 · Cited by 18
PGC-1α–mediated angiogenesis prevents pulmonary hypertension in mice
Fujiwara, T., Takeda, N., Hara, H., Ishii, S., Numata, G., Tokiwa, H., Katoh, M., Maemura, S., Suzuki, T., Takiguchi, H., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.162632 · Cited by 17
The Mechanobiology of Vascular Remodeling in the Aging Lung
Dieffenbach, P. B., Aravamudhan, A., Fredenburgh, L. E., & Tschumperlin, D. J. (2021) · Physiology · doi:10.1152/physiol.00019.2021 · Cited by 17
Stem Cell-derived Exosomal MicroRNA as Therapy for Vascular Age-related Diseases
Hang, R., Guo, Z., Liu, Y., & Song, C. (2022) · Aging and Disease · doi:10.14336/ad.2021.1110 · Cited by 17
Tm4sf1 -marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension
Hong, J. S., Wong, B., Huynh, C., Tang, B., Ruffenach, G., Li, M., Umar, S., Yang, X., & Eghbali, M. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0020oc · Cited by 15
Senotherapy for chronic lung disease
Barnes, P. J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100069 · Cited by 17
Xie, J., Tang, Z., Chen, Q., Jia, X., Li, C., Jin, M., Wei, G., Zheng, H., Li, X., Chen, Y., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0215 · Cited by 16
Metabolic regulation of endothelial senescence
Le, N.-T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1232681 · Cited by 15
He, B., Shao, B., Cheng, C., Ye, Z., Yang, Y., Fan, B., Xia, H., Wu, H., Liu, Q., & Zhang, J. (2024) · Toxics · doi:10.3390/toxics12060396 · Cited by 15
Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension
Marinho, Y., Villarreal, E. S., Loya, O., & Oliveira, S. D. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00208.2024 · Cited by 15
Cellular senescence in adult pulmonary hypertension: current state and future challenges
Lemay, S.-E. S., Kuwabara, Y., Bonnet, S., Potus, F., Provencher, S., Adnot, S., & Boucherat, O. (2025) · European Respiratory Review · doi:10.1183/16000617.0030-2025 · Cited by 15
Elimination of Senescent Endothelial Cells: Good or Bad Idea?
Martin, N., Huna, A., & Bernard, D. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.02.009 · Cited by 14
Mechanisms of cellular senescence-induced vascular aging: evidence of senotherapeutic strategies
Mahoney, S. A., Bloom, S. I., Seals, D. R., Donato, A. J., Rossman, M. J., & Clayton, Z. S. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.31 · Cited by 15
Ginsenoside Rg1 Ameliorates Pulmonary Hypertension by Inhibiting cGAS/STING Mediated Cell Senescence
Ding, R., Xie, H., Zhang, Y., Li, Q., Peng, G., Yi, J., Tan, J., Cao, X., Zheng, R., & Dai, A. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s527938 · Cited by 13
Kelly, N. J., & Chan, S. Y. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2311378 · Cited by 14
Novel and emerging therapies in pulmonary arterial hypertension
Cassady, S. J., Soldin, D., & Ramani, G. V. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.1022971 · Cited by 14
Roles and mechanisms of histone methylation in vascular aging and related diseases
Ji, Y., Chen, Z., & Cai, J. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01842-y · Cited by 12
Liu, D., Qin, S., Su, D., Wang, K., Huang, Y., Huang, Y., & Pang, Y. (2021) · ACS Omega · doi:10.1021/acsomega.1c05895 · Cited by 11
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Zhou, Y., Chen, G., Li, X., Li, X., Lin, Z., Liu, L., Pu, D., Chen, J., Chen, Y., Lin, Z., et al. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.11.005 · Cited by 10
Lemay, S.-E. S., Mougin, M., Sauvaget, M., Kabbout, R. E., Valasarajan, C., Yamamoto, K., Martineau, S., Pelletier, A., Bilodeau, C., Grobs, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101964 · Cited by 8
Therapeutic targets for pulmonary arterial hypertension: insights into the emerging landscape
Flores, C. V., & Chan, S. Y. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2507034 · Cited by 8
Katz, M. G., Hadas, Y., Vincek, A. S., Freage-Kahn, L., Shtraizent, N., Madjarov, J. M., Pastuszko, P., & Eliyahu, E. (2023) · Respiratory Research · doi:10.1186/s12931-023-02487-2 · Cited by 7
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function
Culley, M. K., Rao, R. J., Mehta, M., Zhao, J., Khoury, W. E., Harvey, L. D., Perk, D., Tai, Y., Tang, Y., Shiva, S., et al. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107181 · Cited by 8
Self-citationZhou, Y., Yang, K., Zhang, Z., Wei, F., Chen, L., Luo, D., Yang, Z., Zhao, K., Xie, N., Li, W., et al. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00732.2023 · Cited by 6
Emerging roles of senolytics/senomorphics in HIV-related co-morbidities
Kaur, G., Rahman, M. S., Shaikh, S. B., Panda, K., Chinnapaiyan, S., Estevez, M. S., Xia, L., Unwalla, H. J., & Rahman, I. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116179 · Cited by 6
Cellular senescence in age-related cardiovascular disease: past and future
Wu, X., Zhou, Q. S., Huang, Y., Jiang, W., Zhou, J., Qian, K., Pan, Y. P., Wu, Z., Zhang, J., Aimaiti, M., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2025.1721744 · Cited by 7
Kuang, M., Chen, Y., Xing, Y., Du, M., Feng, H., Yang, Q., Wen, D., Li, X., Yang, K., Lin, Z., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02501-7 · Cited by 5
Zhang, M., Li, L., Zhang, W., Li, M., Yan, G., & Tang, C. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111296 · Cited by 5
Hu, J., Singh, P., Li, J., Zhang, J., Li, F., Zhang, H., & Xie, J. (2023) · Biomedicines · doi:10.3390/biomedicines11092351 · Cited by 5
The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
Williams, Z. J., Chow, L., Dow, S., & Pezzanite, L. M. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1369153 · Cited by 5
Meng, Z., Lu, C., Li, J., Liao, J., Wen, H., Li, Y., Huang, F., & Zeng, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-72979-8 · Cited by 6
Procyanidin C1 is a natural agent with senolytic activity against aging and age-related diseasesPreprint
Xu, Q., Fu, Q., Li, Z., Liu, H., Wang, Y., Lin, X., He, R., Zhang, X., Campisi, J., Kirkland, J. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.14.439765 · Cited by 5
Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking
Kabbout, R. E., Azhar, N., Breuils‐Bonnet, S., Martineau, S., Krishna, V., Sundaram, S. K., Boucherat, O., Provencher, S., Bonnet, S., & Potus, F. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0335le · Cited by 4
Wacker, J., Joye, R., & Beghetti, M. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2581340 · Cited by 4
Senescence in pulmonary arterial hypertension: is there a link?
Semen, K. O., & Bast, A. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000879 · Cited by 4
Are Senolytic Agents Guilty of Overkill or Inappropriate Age Discrimination?
Rabinovitch, M. (2023) · Circulation · doi:10.1161/circulationaha.122.060247 · Cited by 4
Self-citationMolecular underpinnings of aging contributing to systemic sclerosis pathogenesis
Yang, M. M., Boin, F., & Wolters, P. J. (2024) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000001061 · Cited by 4
Senotherapeutics: Milestones, innovations, and future prospects
Atasever, E., Atayik, M. C., & Çakatay, U. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.021 · Cited by 3
Chen, M., & Chen, Y. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/9237701 · Cited by 3
Saunders, A., & Michelakis, E. D. (2022) · Circulation · doi:10.1161/circulationaha.122.059810 · Cited by 3
Treat and Repair for Congenital Heart Disease and Pulmonary Hypertension
Ivy, D. D., & Frank, B. S. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100891 · Cited by 3
Hirsch, K., Horn, A. G., Donato, A. J., & Schulze, K. M. (2026) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00104.2026 · Cited by 2
Zhu, R., Liu, X., Shen, Y., Zhu, S., & Shao, L. (2026) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2026.103360 · Cited by 2
Changing cell fate in the wall of pulmonary arteries
Zhang, Y., & Michelakis, E. D. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq1908 · Cited by 2
Haarman, M. G., & Berger, R. M. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-42937-9_92-1 · Cited by 2
Self-citationWiedemann, J., Paruchuru, S. K., den Boef, L. E., Brouwer, U., Silljé, H. H. W., Schouten, E. M., Dickinson, M. G., van Goethem, M., Coppes, R. P., & van Luijk, P. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.07.2330 · Cited by 2
Long-term survival of shunt closure in atrial septal defects with pulmonary arterial hypertension
Chen, W., Chen, J., Peng, M., Luo, J., Qiu, H., Chen, Y., & Li, J. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133094 · Cited by 2
Metadata
- Authors
- van der Feen, D. E., Bossers, G. P. L., Hagdorn, Q. A. J., Moonen, J.-R., Kurakula, K., Szulcek, R., Chappell, J., Vallania, F., Donato, M., Kok, K., Kohli, J. S., Petersen, A. H., van Leusden, T., Demaria, M., Goumans, M.-J. T. H., De Boer, R. A., Khatri, P., Rabinovitch, M., Berger, R. M. F., & Bartelds, B.
- Affiliations
- Center for Congenital Heart Diseases, University Medical Center Groningen, 9713 GZ Groningen, Netherlands.
- University Medical Center Groningen (NL)
- Stanford Medicine (US)
- Leiden University Medical Center (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- European Research Institute for the Biology of Ageing, 9700 AD Groningen, Netherlands.
- Department of Experimental Cardiology, University Medical Center Groningen, 9713 GZ Groningen, Netherlands.
- ORCID
- van der Feen, Diederik E.
- Bossers, Guido P. L.
- Hagdorn, Quint A. J.
- Moonen, Jan-Renier
- Kurakula, Kondababu
- Szulcek, Robert
- Chappell, James
- Vallania, Francesco
- Donato, Michele
- Kok, Klaas
- Kohli, Jaskaren S.
- Demaria, Marco
- Goumans, Marie-José T. H.
- De Boer, Rudolf A.
- Khatri, Purvesh
- Rabinovitch, Marlene
- Berger, Rolf M. F.
- Bartelds, Beatrijs
- Venue
- Science Translational Medicine
- Published
- 2020-07-29
- Volume
- 12
- Issue
- 554
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC7891555
- OpenAlex
- W3045698630
- Cited by
- 150
- References
- 51
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 30 · 2023: 22 · 2022: 31 · 2021: 21 · 2020: 1
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- Dunlevie Family Fund for Adult Congenital Heart Disease
- Royal Netherlands Academy of Arts and Sciences
- Netherlands Organisation for Health Research and Development
- Dutch Heart Foundation
- Netherlands cardiovascular research initiative (CVON-2012-08)
- Dutch federation of university medical centers
- Integrative omics grant
- NIH NHLI RO
- Sebald Fund
- Ter Meulen Fund
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Keywords
- pulmonary arterial hypertension, cellular senescence, congenital heart disease, shunt closure, reversibility, pulmonary endothelial cells, shear stress, senolytic therapy, navitoclax, apoptosis, vascular phenotype
- MeSH terms
- Pulmonary Arterial Hypertension, Animals, Heart Defects, Congenital, Humans, Cellular Senescence, Endothelial Cells, Rats, Familial Primary Pulmonary Hypertension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
